Publication | Open Access
CHF6001 II: A Novel Phosphodiesterase 4 Inhibitor, Suitable for Topical Pulmonary Administration—In Vivo Preclinical Pharmacology Profile Defines a Potent Anti-Inflammatory Compound with a Wide Therapeutic Window
49
Citations
32
References
2015
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1